| Detected | Trial | Change |
|---|---|---|
| 2026-05-21 | NCT06801834 Study of Sacituzumab Govitecan Versus Standard of Care in Participants With Previously… |
Trial sites expanded: 205 -> 210 locations |
| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 3 | |||
| NCT06801834 | Study of Sacituzumab Govitecan Versus Standard of Care in Participants With Previously… | Extensive Stage Small Cell Lung Cancer (ES-SCLC) | Recruiting |
| NCT06203210 | A Study of Ifinatamab Deruxtecan Versus Treatment of Physician's Choice in Subjects With… | Small Cell Lung Cancer | Recruiting |
| NCT05740566 | Study Comparing Tarlatamab With Standard of Care Chemotherapy in Relapsed Small Cell Lung… | Small Cell Lung Cancer (SCLC) | Active, Not Recruiting |
| NCT07365241 | A Study to Evaluate Adverse Events and Change in Disease Activity of Intravenous ABBV-706… | Small Cell Lung Cancer | Not Yet Recruiting |